NDM-4 metallo-β-lactamase with increased carbapenemase activity from escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2184-2186

  Nordmann, Patrice ^a   Boulanger, Anne E ^a   Poirel, Laurent ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZTREONAM; CARBAPENEM; CARBAPENEMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; DORIPENEM; ERTAPENEM; HYDROLASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; NEW DELHI METALLO BETA LACTAMASE 4; NEW DELHI METALLO BETA LACTAMASE 5; PIPERACILLIN; TICARCILLIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIUM ISOLATE; DRUG HYDROLYSIS; ENZYME ACTIVITY; ENZYME KINETICS; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORINS; CLONING, MOLECULAR; DNA, BACTERIAL; ESCHERICHIA COLI; HUMANS; HYDROLYSIS; KINETICS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

EID: 84858633519     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05961-11     Document Type: Article

References (25)

1. Berçot B, Poirel L, Nordmann P. 2011. Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers. Diagn. Microbiol. Infect. Dis. 71:442-445.
2. Bonnin RA, et al. 2011. Carbapenem-hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:349-354.
3. Carattoli A, et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
4. Chen Y, Zhou Z, Jiang Y, Yu Y. 2011. Emergence of NDM-1 producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66:1255-1259.
5. IMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin. Infect. Dis. 52:692-693.
6. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
7. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Espinal P, et al. 2011. Dissemination of the NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55:5396-5398.
9. Hornsey M, Phee L, Wareham DW. 2011. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55:5952-5954.
10. Reference deleted.
11. Kaase M, et al. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260-1262.
12. NDM-1 and armA in clinical isolates of Acinetobacter baumannii in India. J. Antimicrob. Chemother. 65:2253-2254.
13. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. (Pubitemid 14046088)
14. Kumarasamy KK, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
15. Mammeri H, Van de Loo M, Poirel L, Martinez-Martinez L, Nordmann P. 2005. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49:71-76. (Pubitemid 40065774)
16. Marchiaro P, et al. 2008. Biochemical characterization of metallo-β-lactamase VIM-11 from a Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:2250-2258.
17. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase- producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
18. NDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. 55: 5403-5407.
19. Rodriguez-Martinez J-M, Nordmann P, Fortineau N, Poirel L. 2010. VIM-19, a metallo-β-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471-476.
20. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-β- lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
21. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355-362.
22. Wang J-F, Chou K-C. 2011. Insights from modeling the 3D structure of New Delhi metallo-β-lactamase and its binding interactions with antibiotic drugs. PLoS One 6:e18414.
23. Wirth T, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136-1151.
24. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.
25. Zhang H, Hao Q. 2011. Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism. FASEB J. 25:2574-2782.